Market Indices
Sector Heatmap
RCKT — Rocket Pharmaceuticals, Inc. Common Stock
NasdaqRocket Pharmaceuticals, Inc. Common Stock
- O
- 2.45
- H
- 2.64
- L
- 2.42
- V
- 2.81M
RCKT — Latest News & Headlines
20 StoriesFive of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. - Stock Titan
Five of six patients had lower heart muscle measurements about 3 to 7 years after gene therapy. Stock Titan
Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data - Slideshow (NASDAQ:RCKT) 2026-10-07 - Seeking Alpha
Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data - Slideshow (NASDAQ:RCKT) 2026-10-07 Seeking Alpha
Goldman Sachs Upgrades Rocket Pharmaceuticals (RCKT) to Neutral on RP-A501 Progress - GuruFocus
Goldman Sachs Upgrades Rocket Pharmaceuticals (RCKT) to Neutral on RP-A501 Progress GuruFocus
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT) The Globe and Mail
Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility - Proactive financial news
Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility Proactive financial news
Leerink Partners maintains Market Perform rating on Rocket Pharmaceuticals, $4 price target - TradingView
Leerink Partners maintains Market Perform rating on Rocket Pharmaceuticals, $4 price target TradingView
Cantor Fitzgerald reiterates Rocket Pharmaceuticals stock rating By Investing.com - Investing.com India
Cantor Fitzgerald reiterates Rocket Pharmaceuticals stock rating By Investing.com Investing.com India
This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday Benzinga
RCKT Reiterates by Wedbush -- Price Target Maintained at $15.00 - GuruFocus
RCKT Reiterates by Wedbush -- Price Target Maintained at $15.00 GuruFocus
Rocket Pharma updates progress on RP-A501 for Danon disease - Seeking Alpha
Rocket Pharma updates progress on RP-A501 for Danon disease Seeking Alpha
Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock - AD HOC NEWS
Rocket secures up to USD 150 million: what it means for Rocket Pharmaceuticals stock AD HOC NEWS
Jefferies cuts Rocket Pharmaceuticals stock price target on timeline By Investing.com - Investing.com Nigeria
Jefferies cuts Rocket Pharmaceuticals stock price target on timeline By Investing.com Investing.com Nigeria
Rocket Pharmaceuticals (RCKT) Advances Danon Disease Phase 2 Tri - GuruFocus
Rocket Pharmaceuticals (RCKT) Advances Danon Disease Phase 2 Tri GuruFocus
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist - TradingView
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist TradingView
RCKT Maintains Rating by Leerink Partners -- Price Target Lowered to $4.00 - GuruFocus
RCKT Maintains Rating by Leerink Partners -- Price Target Lowered to $4.00 GuruFocus
Why is Rocket Pharmaceuticals stock up 3% today? By Investing.com - Investing.com UK
Why is Rocket Pharmaceuticals stock up 3% today? By Investing.com Investing.com UK
RCKT Maintained by Chardan Capital -- Price Target Stays at $11 - GuruFocus
RCKT Maintained by Chardan Capital -- Price Target Stays at $11 GuruFocus
Rocket Pharmaceuticals (RCKT) Advances Phase 2 Trial for Danon D - GuruFocus
Rocket Pharmaceuticals (RCKT) Advances Phase 2 Trial for Danon D GuruFocus
Rocket Pharmaceuticals, Inc. Comprehensive Danon Disease Program Webinar Transcript - GuruFocus
Rocket Pharmaceuticals, Inc. Comprehensive Danon Disease Program Webinar Transcript GuruFocus
Rocket Pharmaceuticals Secures Hercules Loan to Extend Runway - TipRanks
Rocket Pharmaceuticals Secures Hercules Loan to Extend Runway TipRanks